Analysis of apoptosis morphology in Epstein-Barr virus positive and negative Burkitt's lymphoma cells

Archives of Histology and Cytology

Volumn 60, Issue 2, 1997, Pages 143-152

  Ishii, Hideaki ^a   Gobé, Glenda C ^b   Joshita, Takashi ^c   Kurabayashi, Yoshiyuki ^c   Hosomura, Yasuo ^c   Kameya, Toru ^a  

^a KITASATO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b UNIVERSITY OF QUEENSLAND   (Australia)

^c GUNMA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

APOPTOSIS; ARTICLE; BURKITT LYMPHOMA; CANCER CELL CULTURE; CELL ULTRASTRUCTURE; EPSTEIN BARR VIRUS; HUMAN; HUMAN CELL; VIRUS DETECTION;

EID: 0030845407     PISSN: 09149465     EISSN: None     Source Type: Journal    
DOI: 10.1679/aohc.60.143     Document Type: Article

References (35)

1. AMEISEN, J. C. and A. CAPRON: Cell dysfunction and depletion in AIDS: the programmed cell death hypothesis. Immunol. Today 12: 102-105 (1991).
2. BERGAMINI, A., L. DINI, M. CAPOZZI, L. GHIBELLI, R. PLACIDO, E. FAGGIOLI, A. SALANITRO, E. BUONANNO, L. CAPPANNOLI, L. VENTURA, M. CEPPARULO, L. FALASCA and G. ROCCHI: Human immunodeficiency virus-induced cell death in cytokine-treated macrophages can be prevented by compounds that inhibit late stages of viral replication. J. Infect. Diseases 173: 1367-1378 (1996).
3. CALENDER, A., M. BILLAUD, J. P. AUBRY, J. BANCHEREAU, M. VUILLAUME and G. M. LENOIR: Epstein-Barr virus (EBV) induces expression of B-cell activation markers on in vitro infection of EBV-negative B-lymphoma cells. Proc. Nat. Acad. Sci. USA 84: 8060-8064 (1987).
4. CAUDWELL, V., F. PORTEU, A. CALENDER, M. K. PANGBURN and L. HALBWACHS-MECARELLI: Complément alternative pathway activation and control on membranes of human lymphoid B cell lines. Eur. J. Immunol. 20: 2643-2650 (1990).
5. CHIRMULE, N. and S. PAHWA: Envelope glycoproteins of human immunodeficiency virus type 1: profound influences on immune functions. Microbiol. Rev. 60: 386-406 (1996).
6. CLEMENTS, G. B., G. KLEIN and S. POVEY: Production by EBV infection of an EBNA-positive subline from an EBNA-negative human lymphoma cell line without detectable EBV DNA. Int. J. Cancer 16: 125-133 (1975).
7. COLLINS, R. J., B. V. HARMON, T. SOUVLIS, J. H. POPE and J. F. R. KERR: Effects of cycloheximide on B-chronic lymphocytic leukaemic and normal lymphocytes in vitro: induction of apoptosis. Brit. J. Cancer 64: 518-522 (1991).
8. DESPRÈS, P., M. FLAMAND, P. E. CECCALDI and V. DEUBEL: Human isolates of dengue type 1 virus induce apoptosis in mouse neuroblastoma cells. J. Virol. 70: 4090-4096 (1996).
9. DIPASQUALE, B. and R. J. YOULE: Programmed cell death in heterokaryons: a study of the transfer of apoptosis between nuclei. Amer. J. Pathol. 141: 1471-1479 (1992).
10. DUDHANE, A., Z. Q. WANG, T. ORLIKOWSKY, A. GUPTA, G. P. WORMSER, H. HOROWITZ, P. KUFER and M. K. HOFFMANN: AIDS patient monocytes target CD4 T cells for cellular conjugate formation and deletion through the membrane expression of HIV-1 envelope molecules. AIDS Res. Hum. Retroviruses 12: 893-899 (1996).
11. EPSTEIN, M. A.: Infection and tumour induction. Nature 321: 653-654 (1986).
12. GREGORY, C. D., C. DIVE, S. HENDERSON, C. A. SMITH, G. T. WILLIAMS, J. GORDON and A. B. RICKINSON: Activation of Epstein-Barr virus latent genes protects human B cells from death by apoptosis. Nature 349: 612-614 (1991).
13. HARMON, B. V., A. M. CORDER, R. J. COLLINS, G. C. GOBÉ, J. ALLEN, D. J. ALLAN and J. F. R. KERR: Cell death induced in a murine mastocytoma by 42-47°C heating in vitro: evidence that the form of death changes from apoptosis to necrosis above a critical heat load. Int. J. Radiat. Biol. 58: 845-858 (1990).
14. HAUSEN, H. ZUR: Viruses in human cancers. Science 254: 1167-1173 (1991).
15. HENDERSON, S., M. ROWE, C. GREGORY, D. CROOM-CARTER, F. WANG, R. LONGNECKER, E. KIEFF and A. RICKINSON: Induction of bcl-2 expression by Epstein-Barr virus latent membrane protein 1 protects infected B cells from programmed cell death. Cell 65: 1107-1115 (1991).
16. HOCKENBERY, D., G. NUÑEZ, C. MILLIMAN, R. D. SCHREIBER and S. J. KORSMEYER: Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature 348: 334-336 (1990).
17. INOUYE, M., M. TAMARU and Y. KAMEYAMA: Effects of cycloheximide and actinomycin D on radiation-induced apoptotic cell death in the developing mouse cerebellum. Int. J. Radiat. Biol. 61: 669-674 (1992).
18. ISHII, H. H., M. R. ETHEEIDGE and G. C. GOBÉ: Cycloheximide-induced apoptosis in Burkitt lymphoma (BJA-B) cells with and without Epstein-Barr virus infection. Immunol. Cell Biol. 73: 463-468 (1995).
19. JOE, A. K., G. FERRARI, H. H. JIANG, X. H. LIANG and B. LEVINE: Dominant inhibitory Ras delays Sindbis virus-induced apoptosis in neuronal cells. J. Virol. 70: 7744-7751 (1996).
20. KERR, J. F. R., A. H. WYLLIE and A. R. CURRIE: Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Brit. J. Cancer 26: 239-257 (1972).
21. KERR, J. F. R. and B. V. HARMON: Definition and incidence of apoptosis: an historical perspective. In: (ed. by) L. D. TOMEI and F. O. COPE: Apoptosis: the molecular basis of cell death. Cold Spring Harbor Laboratory Press, New York. 1991 (p. 5-29).
22. KERR, J. F. R., C. M. WINTERFORD and B. V. HARMON: Apoptosis: its significance in cancer and cancer therapy. Cancer 73: 2013-2026 (1994).
23. KERR, J. F. R., G. C. GOBÉ, C. M. WINTERFORD and B. V. HARMON: Anatomical methods in cell death. In: (ed. by) L. M. SCHWARTZ and B. A. OSBORNE: Methods in cell biology. Academic Press. Orlando. 1995 (p. 1-27).
24. LAUX, G., M. PERRICAUDET and P. J. FARRELL: A spliced Epstein-Barr virus gene expressed in immortalized lymphocytes is created by circularization of the linear viral genome. EMBO J. 7: 769-774 (1988).
25. LEE, Y. J., W. C. DEWEY and G. C. LI: Protection of Chinese hamster ovary cells from heat killing by treatment with cycloheximide or puromycin: involvement of HSPs? Radiat. Res. 3: 237-253 (1987).
26. MARTIN, S. J., S. V. LENNON, A. M. BONHAM and T. G. COTTER: Induction of apoptosis (programmed cell death) in human leukemic HL-60 cells by inhibition of RNA or protein synthesis. J. Immunol. 145: 1859-1867 (1990).
27. NUÑEZ, G., L. LONDON, D. HOCKENBERY, M. ALEXANDER, J. P. MCKEARN and S. J. KORSMEYER: Deregulated Bcl-2 gene expression selectively prolongs survival of growth factor-deprived hemopoietic cell lines. J. Immunol. 144: 3602-3610 (1990).
28. OLSEN, C. W., N. DYBDAHL-SISSOKO and V. S. HINSHAW: The influence of calcium and reactive oxygen species on influenza virus-induced apoptosis. Cell Death Different. 3: 191-197 (1996).
29. SILINS, S. L. and T. B. SCULLEY: Burkitt's lymphoma cells are resistant to programmed cell death in the presence of the Epstein-Barr virus latent antigen EBNA-4. Int. J. Cancer 60: 65-72 (1995).
30. STEINITZ, M. and G. KLEIN: Comparison between growth characteristics of an Epstein-Barr virus (EBV)-genome-negative lymphoma line and its EBV-converted sub-line in vitro. Proc. Nat. Acad. Sci. USA 72: 3518-3520 (1975).
31. TESCH, H., H. ABTS, M. JÜCKER, K. MAYS, G. LENOIR and V. DIEHL: Expression of c-fgr in EBV positive and negative B cell tumors. Leukemia 3: 897-898 (1989).
32. TSUJIMOTO, Y.: Overexpression of the human BCL-2 gene product results in growth enhancement of Epstein-Barr virus-immortalized B cells. Proc. Nat. Acad. Sci. USA 86: 1958-1962 (1989).
33. WALKER, N. L, B. V. HARMON, G. C. GOBÉ and J. F. R. KERR: Patterns of cell death. Methods Achiev. Exp. Pathol. 13: 18-54 (1988).
34. WILLIAMS, G. T.: Programmed cell death: apoptosis and oncogenesis. Cell 65: 1097-1098 (1991).
35. WYLLIE, A. H.: Apoptosis and the regulation of cell numbers in normal and neoplastic tissues: an overview. Cancer Metas. Rev. 11: 95-103 (1992).